A
web-based Atlas of Patient-Derived Xenografts
of cancer patients:A resource of MURAL PDX data
PDX model details
| PDX ID | 1001R |
|---|---|
| Host Strain(and Source) | NSG Source: Monash University |
| Host Strain Immune system Humanized | NO |
| Host Type | None |
| Graft Site | None |
| Current Generation (* indicates number of generations grown in Castrate host) |
1000 |
| Average PDX Generation Time (days +/- SEM) | 1000 |
| Tumor preparation | tumor solid |
| Tumor Characterization Technology | Histology |
| Tumor confirmed not to be of Mouse/EBV origin | Yes |
| Passage QA performed | Routine QA every 2-3 passages |
| Associated meta data | |
| PDX model availability | None |
| Governance restriction for distribution | Available to investigator |
| Pubmed ID | 10000 |
| Markers | 1001R |
|---|---|
| AR | Y |
| PSA | N |
| PSMA | N |
| NE | N |
| ERG | N |
No information in CNV Table
Clinical Information
| Sample Number | 1001T |
|---|---|
| Sample Site | Dura |
| Sample source | Biopsy |
| Pathology Tumor Diagnosis | None |
| Gleason Score | None |
| Primary Gleason Score | None |
| Secondary Gleason Score | None |
| Tertiary Gleason Score | None |
| ISUP Grade Group | None |
| Tumor Grade | None |
| D'Amico Risk Classification | None |
| Tumor Volume (in cc) | None |
| Treatment Prior to Specimen Collection | None |
Patient Information
| Patient Number | 1001 |
|---|---|
| Sex | Male |
| Diagnosis | Prostate Cancer |
| PSA at diagnosis (ng/mL) | 5.2 |
| Consent to share data | |
| Patient Tumor Collection (Current Model) | |
|---|---|
| Tumour sample ID | 1001T |
| Patient Age (binned in 5 year age groups) | 45-60 |
No information in Mutation Table
No information in Gene expression
No information in Drug dosing Table